Erratum: DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: Choice of technique and purification influence the identification of potential diagnostic markers (Leukemia (2003) vol. 17 (1324-1332) 10.1038/sj.leu.2402974);DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: Choice of technique and purification influence the identification of potential diagnostic markers

Leukemia

Volumn 17, Issue 7, 2003, Pages 1324-1332

  Staal, F J T ^a   van der Burg, M ^a   Wessels, L F A ^b   Barendregt, B H ^a   Baert, M R M ^a   van den Burg, C M M ^a   Van Huffel, C ^a   Langerak, A W ^a   van der Velden, V H J ^a   Reinders, M J T ^b   van Dongen, J J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

DNA microarray; Gene expression profiling; Precursor B ALL; Relapse

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW CELL; CANCER RECURRENCE; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC TRANSCRIPTION; HUMAN; INFANT; MALE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; PURIFICATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

EID: 0038103843     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403373     Document Type: Erratum

References (15)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC. Distinct types of diffuse large B-cell lymphomaQ2 identified by gene expression profiling. Nature 2000; 403: 503-511.
2. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
3. Davis RE, Staudt LM. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr Opin Hematol 2002; 9: 333-338.
4. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
6. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639-1647.
7. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ. High density synthetic oligonucleotide arrays. Nat Genet 1999; 21: 20-24.
8. Yang YH, Dudoit S, Luu P, Speed TP. Q3 Normalization for cDNA microarray data. San Jose: SPIE BiOS, 2001.
9. Westfall PH, Krishen A, Young SS. Using prior information to allocate significance levels for multiple endpoints. Stat Med 1998; 17: 2107-2119.
10. Westfall PH, Zaykin DV, Young SS. Multiple tests for genetic effects in association studies. Methods Mol Biol 2002; 184: 143-168.
11. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
12. Hitoshi Y, Lorens J, Kitada SI, Fisher J, LaBarge M, Ring HZ. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 1998; 8: 461-471.
13. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143.
14. De Haas V, Verhagen OJ, von dem Borne AE, Kroes W, van den Berg H, van der Schoot CE. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. Leukemia 2001; 15: 134-140.
15. Szczepanski T, Willemse MJ, Brinkhof B, van Wering ER, van der Burg M, van Dongen JJ. Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. Blood 2002; 7: 2315-2323.